Nachrichten zur Vaxart Inc. Aktie

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”)…

Oral Vaccine Focused Penny Stock Vaxart Is Uniquely Positioned, Analyst Sees Almost 83% Upside

Oppenheimer initiated coverage on Vaxart Inc. (NASDAQ:VXRT), an American biotechnology company focused on the discovery, development, and commercialization of oral…

Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript

…

Vaxart Inc: Asymmetric Risk-Reward Opportunity Following BARDA Funding

…

Vaxart Announces $40 Million Underwritten Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an…

Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript

…

Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript

…